Eikon Therapeutics
Maxim Schillebeeckx is a highly accomplished individual with a background in business development, licensing, and alliance management in the biopharma and healthcare industries. With a strong foundation in molecular genetics and genomics, Maxim has held key roles in companies such as Eikon Therapeutics, The BALSA Foundation, Guardant Health, and BioReference Laboratories. Maxim's expertise lies in identifying, evaluating, and leading due diligence for technology platforms in oncology, establishing research collaborations, and driving commercial growth for genomic medicine platforms. With a Ph.D. in Molecular Genetics and Genomics, Maxim brings a unique blend of scientific knowledge and business acumen to the organizations Maxim works with.
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.